{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:38:50Z","timestamp":1784709530836,"version":"3.55.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Scientific African"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.sciaf.2022.e01407","type":"journal-article","created":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T12:33:48Z","timestamp":1666442028000},"page":"e01407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Common NLRP3 inflammasome inhibitors and Covid-19: Divide and conquer"],"prefix":"10.1016","volume":"18","author":[{"given":"Gaber El-Saber","family":"Batiha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3721-8065","authenticated-orcid":false,"given":"Damilare","family":"Rotimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9342-8505","authenticated-orcid":false,"given":"Oluyomi Stephen","family":"Adeyemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder M.","family":"Al-kuraishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.sciaf.2022.e01407_bib0001","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016287","article-title":"Inflammasomes","volume":"6","author":"De Zoete","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.sciaf.2022.e01407_bib0002","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/imr.12534","article-title":"Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases","volume":"277","author":"Man","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0003","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fimmu.2014.00300","article-title":"Pattern recognition receptors and autophagy","volume":"5","author":"Oh","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0004","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3389\/fimmu.2013.00440","article-title":"An update on PYRIN domain-containing pattern recognition receptors: from immunity to pathology","volume":"4","author":"Ratsimandresy","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fmicb.2011.00003","article-title":"Inflammasomes: caspase-1-activating platforms with critical roles in host defense","volume":"2","author":"Vande Walle","year":"2011","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0006","article-title":"Inflammatory response in relation to COVID-19 and other prothrombotic phenotypes","author":"P\u00e1ramo","year":"2020","journal-title":"Reumatol. Cl\u00edn."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0007","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3389\/fimmu.2015.00570","article-title":"Bacterial exotoxins and the inflammasome","volume":"6","author":"Greaney","year":"2015","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.sciaf.2022.e01407_bib0008","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2174\/1566524019666190826143749","article-title":"Frequency of interleukins IL1\u00df\/IL18 and inflammasome NLRP1\/NLRP3 polymorphisms in sickle cell anemia patients and their association with severity score","volume":"19","author":"de Almeida","year":"2019","journal-title":"Curr. Mol. Med."},{"issue":"5","key":"10.1016\/j.sciaf.2022.e01407_bib0009","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s10875-010-9440-3","article-title":"Molecular mechanism of NLRP3 inflammasome activation","volume":"30","author":"Jin","year":"2010","journal-title":"J. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.sciaf.2022.e01407_bib0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrrheum.2012.143","article-title":"Uric acid as a danger signal in gout and its comorbidities","volume":"9","author":"Rock","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0011","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.atherosclerosis.2017.10.027","article-title":"NLRP3 inflammasome pathways in atherosclerosis","volume":"267","author":"Baldrighi","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.sciaf.2022.e01407_bib0012","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.3389\/fimmu.2019.02578","article-title":"L\u00f3pez-Vales R. Olt1177 (dapansutrile), a selective nlrp3 inflammasome inhibitor, ameliorates experimental autoimmune encephalomyelitis pathogenesis","volume":"10","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0013","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3389\/fimmu.2018.00913","article-title":"NLRP3 inflammasome and caspase-1\/11 pathway orchestrate different outcomes in the host protection against Trypanosoma cruzi acute infection","volume":"9","author":"Paroli","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.sciaf.2022.e01407_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-26603-1","article-title":"The mitochondrial protease HtrA2 restricts the NLRP3 and AIM2 inflammasomes","volume":"8","author":"Rodrigue-Gervais","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.sciaf.2022.e01407_bib0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-065X.2011.01050.x","article-title":"Intracellular sensing of microbes and danger signals by the inflammasomes","volume":"243","author":"Horvath","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0016","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3389\/fmed.2020.546445","article-title":"Adiponectin inhibits NLRP3 inflammasome activation in nonalcoholic steatohepatitis via AMPK-JNK\/ErK1\/2-NF\u03baB\/ROS signaling pathways","volume":"7","author":"Dong","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0017","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3389\/fimmu.2017.01017","article-title":"Outer membrane vesicles prime and activate macrophage inflammasomes and cytokine secretion in vitro and in vivo","volume":"8","author":"Cecil","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0018","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fcimb.2019.00406","article-title":"ZBP1 and TAK1: master regulators of NLRP3 inflammasome\/pyroptosis, apoptosis, and necroptosis (PAN-optosis)","volume":"9","author":"Malireddi","year":"2019","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"4","key":"10.1016\/j.sciaf.2022.e01407_bib0019","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/JMAU.JMAU_63_20","article-title":"COVID-19 and phosphodiesterase enzyme type 5 inhibitors","volume":"8","author":"Al-Kuraishy","year":"2020","journal-title":"J. Microsc. Ultrastruct."},{"issue":"5","key":"10.1016\/j.sciaf.2022.e01407_bib0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/bbrj.bbrj_105_20","article-title":"Renin\u2013Angiotensin system and fibrinolytic pathway in COVID-19: one-way skepticism","volume":"4","author":"Al-Kuraishy","year":"2020","journal-title":"Biomed. Biotechnol. Res. J. (BBRJ)"},{"issue":"3","key":"10.1016\/j.sciaf.2022.e01407_bib0021","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4103\/2305-0500.282984","article-title":"COVID-19 pneumonia in an Iraqi pregnant woman with preterm delivery","volume":"9","author":"Al-kuraishy","year":"2020","journal-title":"Asian Pac. J. Reprod."},{"issue":"18","key":"10.1016\/j.sciaf.2022.e01407_bib0022","first-page":"1775","article-title":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","volume":"323","author":"Onder","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.sciaf.2022.e01407_bib0023","first-page":"1","article-title":"Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing","volume":"6","author":"Wen","year":"2020","journal-title":"Cell Discov."},{"issue":"2","key":"10.1016\/j.sciaf.2022.e01407_bib0024","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/bpa.12483","article-title":"Inflammasome activation and innate immunity in Alzheimer's disease","volume":"27","author":"Heneka","year":"2017","journal-title":"Brain Pathol."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fmicb.2019.00050","article-title":"Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Microbiol."},{"issue":"10","key":"10.1016\/j.sciaf.2022.e01407_bib0026","doi-asserted-by":"crossref","first-page":"e3074","DOI":"10.1038\/cddis.2017.470","article-title":"NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension","volume":"8","author":"Sun","year":"2017","journal-title":"Cell Death. Dis."},{"issue":"1","key":"10.1016\/j.sciaf.2022.e01407_bib0027","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/22221751.2020.1747363","article-title":"Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients","volume":"9","author":"Xiong","year":"2020","journal-title":"Emerging Microbes Infect."},{"issue":"10","key":"10.1016\/j.sciaf.2022.e01407_bib0028","first-page":"991","article-title":"Middle East respiratory syndrome novel corona (MERS-CoV) infection","volume":"34","author":"Al-Tawfiq","year":"2013","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0029","first-page":"2013","article-title":"IL-1\u03b2 and IL-6 upregulation in children with H1N1 influenza virus infection","author":"Chiaretti","year":"2013","journal-title":"Mediators Inflamm."},{"issue":"7","key":"10.1016\/j.sciaf.2022.e01407_bib0030","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122678","article-title":"IL-1 receptor antagonist therapy mitigates placental dysfunction and perinatal injury following Zika virus infection","volume":"4","author":"Lei","year":"2019","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.sciaf.2022.e01407_bib0031","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201707","article-title":"Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients","volume":"218","author":"Rodrigues","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0032","first-page":"1","article-title":"Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools","author":"Fu","year":"2020","journal-title":"Virol. Sin."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0033","first-page":"1","article-title":"The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection","author":"Gallo","year":"2020","journal-title":"Mucosal. Immunol."},{"issue":"6","key":"10.1016\/j.sciaf.2022.e01407_bib0034","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.jaip.2020.04.014","article-title":"Weathering the cytokine storm in susceptible patients with severe SARS-CoV-2 infection","volume":"8","author":"Lipworth","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"6","key":"10.1016\/j.sciaf.2022.e01407_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2135","article-title":"Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV","volume":"30","author":"Bouayad","year":"2020","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0036","article-title":"SARS-CoV-2-specific virulence factors in COVID-19","author":"Kumar","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01021","article-title":"Novel coronavirus-induced NLRP3 inflammasome activation: a potential drug target in the treatment of COVID-19","volume":"11","author":"Shah","year":"2020","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.sciaf.2022.e01407_bib0038","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1093\/carcin\/bgs256","article-title":"Genetic variation and alterations of genes involved in NF\u03baB\/TNFAIP3-and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer","volume":"33","author":"Ungerb\u00e4ck","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.sciaf.2022.e01407_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111822","article-title":"Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases","volume":"185","author":"Zhang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25940","article-title":"Persistent viral RNA positivity during the recovery period of a patient with SARS-CoV-2 infection","author":"Yang","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0041","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fimmu.2020.00211","article-title":"NLRP3 inflammasome-a key player in antiviral responses","volume":"11","author":"Zhao","year":"2020","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.sciaf.2022.e01407_bib0042","doi-asserted-by":"crossref","first-page":"9792","DOI":"10.1074\/jbc.M109.082305","article-title":"Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome","volume":"285","author":"Juliana","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0043","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3389\/fphar.2020.588467","article-title":"Phytochemicals: potential therapeutic interventions against coronavirus-associated lung injury","volume":"11","author":"Majnooni","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.sciaf.2022.e01407_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms12504","article-title":"Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models","volume":"7","author":"Daniels","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0045","article-title":"Use of mefenamic acid as a supportive treatment of COVID-19: a repurposing drug","author":"Pareek","year":"2020","journal-title":"Int. J. Sci. Res."},{"issue":"4","key":"10.1016\/j.sciaf.2022.e01407_bib0046","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.apsb.2019.02.008","article-title":"Aspirin alleviates endothelial gap junction dysfunction through inhibition of NLRP3 inflammasome activation in LPS-induced vascular injury","volume":"9","author":"Zhou","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.sciaf.2022.e01407_bib0047","article-title":"Aspirin use is associated with decreased mechanical ventilation, ICU admission, and in-hospital mortality in hospitalized patients with COVID-19","author":"Chow","year":"2020","journal-title":"Anesth. Analg."},{"issue":"1","key":"10.1016\/j.sciaf.2022.e01407_bib0048","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.bbrc.2017.08.060","article-title":"Indomethacin inhabits the NLRP3 inflammasome pathway and protects severe acute pancreatitis in mice","volume":"493","author":"Lu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.sciaf.2022.e01407_bib0049","first-page":"1","article-title":"Low dose indomethacin in the outpatient treatment of COVID-19 in kidney transplant recipients\u2014a case series","volume":"7","author":"Kanakaraj","year":"2020","journal-title":"Open Access Library J."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0050","first-page":"6","article-title":"A paradigm shift in the role of NSAIDs in COVID-19: new pathological mechanisms and potential treatment targets","volume":"2","author":"Ilie","year":"2020","journal-title":"Atena J. Public Health"},{"issue":"6","key":"10.1016\/j.sciaf.2022.e01407_bib0051","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.immuni.2013.05.015","article-title":"Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation","volume":"38","author":"Yan","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.sciaf.2022.e01407_bib0052","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.biochi.2020.09.003","article-title":"May omega-3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients?","volume":"179","author":"Weill","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.sciaf.2022.e01407_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.freeradbiomed.2020.07.005","article-title":"Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19","author":"Rogero","year":"2020","journal-title":"Free Radical Biol. Med."},{"issue":"4","key":"10.1016\/j.sciaf.2022.e01407_bib0054","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4103\/japtr.JAPTR_317_18","article-title":"Sulfonylurea and neuroprotection: the bright side of the moon","volume":"9","author":"Hussien","year":"2018","journal-title":"J. Adv. Pharm. Technol. Res."},{"issue":"6","key":"10.1016\/j.sciaf.2022.e01407_bib0055","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.imbio.2019.08.008","article-title":"NLRP3 inflammasome inhibitor glyburide expedites diabetic-induced impaired fracture healing","volume":"224","author":"Yang","year":"2019","journal-title":"Immunobiology"},{"issue":"3","key":"10.1016\/j.sciaf.2022.e01407_bib0056","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/japtr.JAPTR_18_20","article-title":"Metformin and\/or vildagliptin mitigate type II diabetes mellitus induced-oxidative stress: the intriguing effect","volume":"11","author":"Al-Kuraishy","year":"2020","journal-title":"J. Adv. Pharm. Technol. Res."},{"issue":"5","key":"10.1016\/j.sciaf.2022.e01407_bib0057","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.7150\/ijbs.29680","article-title":"Metformin inhibits the NLRP3 inflammasome via AMPK\/mTOR-dependent effects in diabetic cardiomyopathy","volume":"15","author":"Yang","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.sciaf.2022.e01407_bib0058","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.diabet.2020.07.006","article-title":"Metformin and COVID-19: from cellular mechanisms to reduced mortality","volume":"46","author":"Scheen","year":"2020","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0059","doi-asserted-by":"crossref","unstructured":"C. Bramante, N. Ingraham, T. Murray, S. Marmor, S. Hoversten, J. Gronski, C. McNeil, R. Feng, G. Guzman, N. Abdelwahab, S. King. Observational study of metformin and risk of mortality in patients hospitalized with Covid-19. medRxiv. 2020 Jan 1. doi:10.1101\/2020.06.19.20135095.","DOI":"10.1101\/2020.06.19.20135095"},{"issue":"7","key":"10.1016\/j.sciaf.2022.e01407_bib0060","article-title":"Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.sciaf.2022.e01407_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109776","article-title":"Can pioglitazone be potentially useful therapeutically in treating patients with covid-19?","author":"Carboni","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"4","key":"10.1016\/j.sciaf.2022.e01407_bib0062","doi-asserted-by":"crossref","first-page":"e8689","DOI":"10.15252\/emmm.201708689","article-title":"Tranilast directly targets NLRP 3 to treat inflammasome-driven diseases","volume":"10","author":"Huang","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2020.03.006","article-title":"Ongoing clinical trials for the management of the COVID-19 pandemic","author":"Lythgoe","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"issue":"26","key":"10.1016\/j.sciaf.2022.e01407_bib0064","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.sciaf.2022.e01407_bib0065","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s10067-020-05247-5","article-title":"Colchicine as a possible therapeutic option in COVID-19 infection","volume":"39","author":"Parra-Medina","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0066","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.biopha.2016.09.020","article-title":"Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation","volume":"84","author":"Jiang","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0067","doi-asserted-by":"crossref","unstructured":"I. Mittra, R. de Souza, R. Bhadade, T. Madke, P.D. Shankpal, M. Joshi, B. Qayyumi, A. Bhattacharya, V. Gota, S. Gupta, P. Chaturvedi. Resveratrol and copper for treatment of severe COVID-19: an observational study (RESCU 002). medRxiv. 2020 Jan 1. doi:10.1101\/2020.07.21.20151423.","DOI":"10.1101\/2020.07.21.20151423"},{"key":"10.1016\/j.sciaf.2022.e01407_bib0068","article-title":"An approach of fatty acids and resveratrol in the prevention of COVID-19 severity","author":"Hoang","year":"2020","journal-title":"Phytother. Res."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0069","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.intimp.2019.05.006","article-title":"NLRP3 inflammasome as a treatment target in atherosclerosis: a focus on statin therapy","volume":"73","author":"Parsamanesh","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.sciaf.2022.e01407_bib0070","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1124\/mol.116.108100","article-title":"Statins attenuate activation of the NLRP3 inflammasome by oxidized LDL or TNF\u03b1 in vascular endothelial cells through a PXR-dependent mechanism","volume":"92","author":"Wang","year":"2017","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.sciaf.2022.e01407_bib0071","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/21623945.2015.1024394","article-title":"Is immunity a mechanism contributing to statin-induced diabetes?","volume":"4","author":"Henriksbo","year":"2015","journal-title":"Adipocyte"},{"key":"10.1016\/j.sciaf.2022.e01407_bib0072","article-title":"Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways","author":"Koushki","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.sciaf.2022.e01407_bib0073","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.amjcard.2020.08.004","article-title":"Meta-analysis of effect of statins in patients with COVID-19","volume":"134","author":"Kow","year":"2020","journal-title":"Am. J. Cardiol."}],"container-title":["Scientific African"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468227622003131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468227622003131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T05:37:13Z","timestamp":1762839433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468227622003131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":73,"alternative-id":["S2468227622003131"],"URL":"https:\/\/doi.org\/10.1016\/j.sciaf.2022.e01407","relation":{},"ISSN":["2468-2276"],"issn-type":[{"value":"2468-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Common NLRP3 inflammasome inhibitors and Covid-19: Divide and conquer","name":"articletitle","label":"Article Title"},{"value":"Scientific African","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sciaf.2022.e01407","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of African Institute of Mathematical Sciences \/ Next Einstein Initiative.","name":"copyright","label":"Copyright"}],"article-number":"e01407"}}